Ben Liu
@BenjamineYLiu
Followers
2K
Following
471
Media
5
Statuses
94
co-founder and CEO @formationbio
New York
Joined September 2014
Excited to announce our license of Gusacitinib to @sanofi for upwards of €545M in upfront and milestones in addition to royalties in the low to mid-teen based on future sales.
14
4
100
Excited to share an update at @formationbio: We’ve added @Imidomics first-in-class anti-CD226 antibody to our pipeline — a Phase 1–ready program for Ulcerative Colitis. Grateful to Fred Craves & Sandy Zweifach for the collaboration and shared vision for the program’s future.
@IMIDomics discovered the initial science, and now.@formationbio is taking it forward to clinical development. Today we announced our license of IMIDomics' first-in-class, Phase-1 ready anti-CD226 antibody targeting Ulcerative Colitis. Go behind the scenes with both teams here.
4
8
67
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
358
644
3K
Enjoyed chatting with the team @a16z and @Techweek_. Not sure that Art Levinson (now @calico) remembers our call, but his advice left an indelible impact on how we think about mission, values, and cultural inertia.
If you’re building for 10+ years, “just get started” won’t cut it. @BenjamineYLiu (CEO/cofounder of @formationbio ) says: ask the counterfactual. Would the world be any different if your company didn’t exist?. If not, go back to the whiteboard.
0
1
9
0
1
0
So grateful for the team at @formationbio for all the incredible work and our collaborators at @sanof, Asana BioSciences and @Tarsadia_Inv for the partnership on this program.
0
0
4
In the long run, we plan to go end-to-end, leveraging our AI systems to develop and commercialize our own drugs to transform the speed, efficiency, and accessibility of drugs to patients.
1
0
5
This is a meaningful proof point for @formationbio on our journey to create this generation’s AI native company. In the short term, our business model involves partnering or selling drug assets back to pharma after key value inflection points.
1
0
8
This is a meaningful proof point for @formationbio on our journey to create this generation’s AI native company. In the short term, our business model involves partnering or selling drug assets back to pharma after key value inflection points.
0
0
2
Thanks @CNBC @CNBCFastMoney for having me on!.
A disruptor in the AI drug discovery space. @formationbio's @BenjamineYLiu explains how his company is using AI in drug development and what's next for a quickly evolving space.
0
0
4
RT @CNBCFastMoney: A disruptor in the AI drug discovery space. @formationbio's @BenjamineYLiu explains how his company is using AI in dr….
cnbc.com
Formation Bio CEO Benjamine Liu joins 'Fast Money' as Formation comes in at #37 on the Disruptor 50 list.
0
2
0
As AI transform drug discovery, clinical trials and drug development will be the most consequential bottleneck. Excited to be on this year's @CNBCDisruptors list as we look to build this generation's enduring pharma company.
Excited to be named to @CNBCDisruptors 50 List this year. As AI disrupts every industry, we're proud to be leading the way for drug development.
2
1
7
Thrilled to welcome Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President of Pfizer R&D, to Formation Bio to chair our drug picking efforts. As we look to bring together the best of pharma with the best of AI and technology, we are honored to partner with Mikael.
1
3
18
RT @StartingUpGood: AI & Entrepreneurship in 2025: Are one-person billion-dollar businesses possible?.@BenjamineYLiu @formationbio.@dan_mur….
0
2
0
In Chinese culture, they call it 'eating bitterness,' Kobe Bryant called it Mamba Mentality. Read my thoughts on why we must embrace this mentality this Chinese New Year.
benliu.posthaven.com
Growing up, I was the biggest Kobe Bryant fan. I was initially drawn to his swagger and confidence on the court, but as I got older what I admired most about him was his extreme work ethic and his...
2
1
18
RT @AndrewE_Dunn: “If we think about all the drug development activities, we think there’s a Muse for everything,” Formation Bio CEO Benjam….
endpoints.news
A flashy collaboration between Sanofi, OpenAI and Formation Bio produced its first AI-powered tool, aiming to speed up the process of recruiting patients into clinical trials. The tool is called ...
0
7
0
RT @skupor: Great example of a tangible AI use case in one of the most intractable problem areas - drug development. Congrats @formationbio.
0
3
0
